Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for BrightSpring Health Services (BTSG) over the last 3 years, with Q3 2025 value amounting to $140.3 million.

  • BrightSpring Health Services' Cash & Equivalents rose 29013.7% to $140.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.3 million, marking a year-over-year increase of 29013.7%. This contributed to the annual value of $61.0 million for FY2024, which is 36633.0% up from last year.
  • Per BrightSpring Health Services' latest filing, its Cash & Equivalents stood at $140.3 million for Q3 2025, which was up 29013.7% from $70.1 million recorded in Q2 2025.
  • BrightSpring Health Services' Cash & Equivalents' 5-year high stood at $140.3 million during Q3 2025, with a 5-year trough of $13.1 million in Q4 2023.
  • For the 3-year period, BrightSpring Health Services' Cash & Equivalents averaged around $57.0 million, with its median value being $55.2 million (2024).
  • In the last 5 years, BrightSpring Health Services' Cash & Equivalents skyrocketed by 36633.0% in 2024 and then plummeted by 982.13% in 2025.
  • Over the past 3 years, BrightSpring Health Services' Cash & Equivalents (Quarter) stood at $13.1 million in 2023, then soared by 366.33% to $61.0 million in 2024, then skyrocketed by 130.25% to $140.3 million in 2025.
  • Its Cash & Equivalents was $140.3 million in Q3 2025, compared to $70.1 million in Q2 2025 and $52.3 million in Q1 2025.